22,23-Dihydroavermectin B1, ivermectin, derived from avermectin B1 by selective hydrogenation using Wilkinson's homogenous catalyst [Ph3P)3RhCl], was shown to be a highly effective drug for the treatment of a wide variety of metazoan parasitic diseases in animals.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm00184a014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exposure of gut bacterial isolates to the anthelminthic drugs, ivermectin and moxidectin, leads to antibiotic-like phenotypes of growth inhibition and adaptation.
Commun Biol
November 2024
Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
Due to their broad-spectrum activities, ivermectin and moxidectin are widely used anthelminthics in veterinary and human medicine. However, ivermectin has recently been shown to perturbate bacterial growth. Given the macrolide-like structure of both ivermectin and moxidectin, there is a need to characterize the antibiotic spectrum of these anthelminthics and their potential implications in the development of cross-resistance to macrolides and other families of antibiotics.
View Article and Find Full Text PDFIvermectin inhibits the growth of ESCC by activating the ATF4-mediated endoplasmic reticulum stress-autophagy pathway.
Acta Biochim Biophys Sin (Shanghai)
November 2024
Epigenetics & Translational Medicine Laboratory, School of Life Sciences, Henan University, Kaifeng 475004, China.
Esophageal squamous cell carcinoma (ESCC) is one of the most common forms of malignancy worldwide. However, there is currently a lack of effective chemotherapeutic drugs for ESCC. Ivermectin is a broad-spectrum antiparasitic drug with notable antitumor activity.
View Article and Find Full Text PDFPatient-Derived Organoids on a Microarray for Drug Resistance Study in Breast Cancer.
Anal Chem
November 2024
Department of Chemistry, Zhejiang University, Hangzhou 310058, China.
Drug resistance is always a challenge in cancer treatment, whether for chemotherapy, targeting, or immunotherapy. Although tumor cell lines are derived from cancer patients, they gradually lost the original characteristics, including heterogeneity and tumor microenvironment (TME), during the long period of culturing. Therefore, it is urgent to use patient-derived tumor models instead of cancer cell lines to study tumor drug resistance.
View Article and Find Full Text PDFAdvanced LC-MS/MS Technique for Environmental Ivermectin Detection.
ACS Omega
October 2024
Department of Veterinary Sciences, University of Parma, Strada del Taglio 10, Parma 43126, Italy.
Ivermectin is a widely used broad-spectrum antiparasitic agent employed in both companion animals and livestock. While generally safe for mammals, its acute and chronic toxicity has been proven in many nontarget fish and insect species at low concentrations. The present study aimed to develop, validate, and test a more accurate method for ivermectin detection in various matrices (feces, soil, and sewage) for environmental studies.
View Article and Find Full Text PDFFerulic acid alleviates cardiac injury by inhibiting avermectin-induced oxidative stress, inflammation and apoptosis.
Comp Biochem Physiol C Toxicol Pharmacol
January 2025
Department of Pathology, The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China. Electronic address:
Avermectin (AVM) is a broad-spectrum antibiotic from the macrolide class, extensively employed in fisheries and aquaculture. Nevertheless, its indiscriminate utilisation has resulted in a substantial accumulation of remnants in the aquatic ecosystem, potentially inflicting significant harm to the cardiovascular system of aquatic species. Ferulic acid (FA) is a naturally occurring compound in wheat grain husks.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!